RESEARCH-USE BIOSIMILAR ANTIBODY

Tomuzotuximab

Monoclonal antibody · IgG1

EGFRIgG1RUO

Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects.

TARGETEGFR
YMonoclonal antibody
CATALOGSC-BS-094
CATALOG NUMBERSC-BS-094
MOLECULAR WEIGHTApprox. 145.46 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects.

Tomuzotuximab is a recombinant research-use antibody directed against EGFR.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte